Feature EyeGate developing non-invasive ophthalmic treatments By Len Zehr EyeGate Pharmaceuticals (NASDAQ:EYEG) is developing a non-invasive drug delivery platform that uses an electrical process, known as iontophoresis, to deliver a corticosteroid to the front-and back-of-the-eye... January 19, 2016